Sichuan, China

Wen Ren



Average Co-Inventor Count = 9.5

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations of Inventor Wen Ren in Indoleamine-2,3-Dioxygenase Inhibition

Introduction

Wen Ren is a distinguished inventor based in Sichuan, China, recognized for his significant contributions to the field of pharmaceuticals. With two patents to his name, Wen Ren focuses on vital innovations aimed at combating diseases associated with the indoleamine-2,3-dioxygenase (IDO) metabolic pathways.

Latest Patents

Wen Ren's latest patents include a groundbreaking compound represented by formula (I), specifically designed as an indoleamine-2,3-dioxygenase inhibitor. This innovative compound showcases a remarkable inhibitory effect on IDO protease and demonstrates stable metabolism within the human body. The pharmaceutical composition derived from this compound can be utilized for the development of IDO inhibitor drugs, offering potential treatments for diseases characterized by IDO-mediated tryptophan metabolic pathways.

The second patent emphasizes the preparation method of the compound and its therapeutic uses. The patented methods and compositions enhance the prospective utility of these innovations in pharmaceutical applications, particularly for tackling diseases that stem from certain metabolic dysfunctions.

Career Highlights

Wen Ren is currently associated with Hinova Pharmaceuticals Inc., where he contributes significantly to research and development efforts in the pharmaceutical landscape. His focus on IDO inhibitors reflects a commitment to advancing medical treatments and improving patient outcomes through innovative scientific solutions.

Collaborations

Wen Ren collaborates with notable colleagues, including Wu Du and Haibin Lv, who share a common vision of enhancing drug development and therapeutic strategies. These partnerships foster a creative environment conducive to groundbreaking discoveries in the pharmaceutical sector.

Conclusion

Wen Ren's innovative work in developing indoleamine-2,3-dioxygenase inhibitors positions him as a notable figure in the field of pharmaceutical research. With ongoing collaborations and his dedication to addressing significant health challenges, Wen Ren continues to pave the way for future advancements in drug development and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…